Company Overview#
MEDIHUB is a medical device company developing the i-JECT lineup of digitally controlled automatic injectors. The company aims to shift the injection paradigm by ensuring patients experience less pain and clinicians enjoy greater convenience. Using precision dosing and pain-reduction algorithms, MEDIHUB is expanding its footprint across the dental, medical, and aesthetic markets.
Technology & Product#
The core offering is the i-JECT product family, which includes i-JECT ST for local anesthesia, i-JECT B, i-JECT V, and i-JECT MD. These devices use a pain-relief algorithm and provide precise, automated volume control and constant pressure injection. The i-JECT ST was developed through collaborative research with the Seoul National University Dental Hospital Medical Device R&BD platform. The i-JECT B is specifically designed to reduce procedure pain and minimize drug loss using a patented Low Dead Space syringe.
Market & Use Cases#
MEDIHUB’s injectors target healthcare professionals in dentistry, general medicine, and medical aesthetics who perform frequent local anesthesia or precise drug injections. The devices improve the patient experience by minimizing pain and alleviate the physical strain on clinicians by automating the injection pressure and volume.
Traction & References#
The company has successfully commercialized its i-JECT ST, B, V, and MD product lines. In April 2026, MEDIHUB secured a distribution agreement with L&C Bio for the i-JECT B in domestic and select overseas markets, pairing the injector with L&C Bio’s ECM-based regenerative solution(Seoul Economic Daily). MEDIHUB holds necessary medical device sales and manufacturing licenses and was selected for the TIPS program in 2018.
Collaboration Relevance#
MEDIHUB is well-positioned for distribution and commercial partnerships with medical supply distributors, particularly in the aesthetic and dental sectors. The technology is relevant for pharmaceutical and regenerative medicine companies seeking delivery hardware to enhance the application and reduce the waste of high-value therapeutics.